- Home
- Publications
- Publication Search
- Publication Details
Title
Dendrimers, an Emerging Opportunity in Personalized Medicine?
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 12, Issue 8, Pages 1334
Publisher
MDPI AG
Online
2022-08-22
DOI
10.3390/jpm12081334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curing inflammatory diseases using phosphorous dendrimers
- (2022) Anne‐Marie Caminade et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Astodrimer sodium and bacterial vaginosis: a mini review
- (2022) Werner Mendling et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The DendrisCHIP® Technology as a New, Rapid and Reliable Molecular Method for the Diagnosis of Osteoarticular Infections
- (2022) Elodie Bernard et al. Diagnostics
- Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma
- (2022) Orlagh M. Feeney et al. JOURNAL OF CONTROLLED RELEASE
- Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial
- (2022) Aaron M. Gusdon et al. Science Translational Medicine
- Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
- (2021) Claire M. Patterson et al. Communications Biology
- Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation
- (2021) Musa Khaitov et al. ALLERGY
- Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration
- (2021) Siva P. Kambhampati et al. JOURNAL OF CONTROLLED RELEASE
- A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma
- (2021) Surein Arulananda et al. Cell Death Discovery
- Dendrimer-Based Nanogels for Cancer Nanomedicine Applications
- (2021) Shewaye Lakew Mekuria et al. BIOCONJUGATE CHEMISTRY
- A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
- (2020) Arthur S. Waldbaum et al. PLoS One
- Dendrimer based nanoarchitectures in diabetes management: An overview
- (2019) Vijay Mishra et al. CURRENT PHARMACEUTICAL DESIGN
- Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis
- (2019) Steven E. Chavoustie et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance
- (2018) Val M. Runge et al. INVESTIGATIVE RADIOLOGY
- Multiplexing technology for in vitro diagnosis of pathogens: the key contribution of phosphorus dendrimers
- (2018) Jean Pierre Majoral et al. Science China-Materials
- Review of core-multishell nanostructured models for nano-biomedical and nano-biopharmaceutical application
- (2018) Ana J. Šetrajčić–Tomić et al. BIO-MEDICAL MATERIALS AND ENGINEERING
- Nanotherapeutics for the treatment of cancer and arthritis
- (2018) Pal Patel et al. CURRENT DRUG METABOLISM
- Nanoparticulate Contrast Agents for Multimodality Molecular Imaging
- (2016) Yang Xia et al. Journal of Biomedical Nanotechnology
- Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women
- (2015) Rebecca Pellett Madan et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- The dendrimer paradox – high medical expectations but poor clinical translation
- (2015) Sonke Svenson CHEMICAL SOCIETY REVIEWS
- Multifunctional nanoparticles for use in theranostic applications
- (2015) James T. Cole et al. Drug Delivery and Translational Research
- Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
- (2014) Madaswamy S. Muthu et al. Theranostics
- Glycogen and its metabolism: some new developments and old themes
- (2012) Peter J. Roach et al. BIOCHEMICAL JOURNAL
- Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)
- (2011) Ian McGowan et al. AIDS
- Measurement of Mucosal Biomarkers in a Phase 1 Trial of Intravaginal 3% StarPharma LTD 7013 Gel (VivaGel) to Assess Expanded Safety
- (2011) Anna-Barbara Moscicki et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days
- (2011) Craig R. Cohen et al. PLoS One
- SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
- (2011) Clare F. Price et al. PLoS One
- Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study
- (2010) John OʼLoughlin et al. SEXUALLY TRANSMITTED DISEASES
- A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis
- (2009) Marcus Y Chen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Attitudes of men in an Australian male tolerance study towards microbicide use
- (2009) Wendy R. Holmes et al. Sexual Health
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started